Journal of Endocrinology and Metabolism, ISSN 1923-2861 print, 1923-287X online, Open Access
Article copyright, the authors; Journal compilation copyright, J Endocrinol Metab and Elmer Press Inc
Journal website http://www.jofem.org

Original Article

Volume 7, Number 4, August 2017, pages 117-121


The Influence of Hormonal Contraception on Vitamin D Supplementation on Serum 25(OH)D3 Status in Premenopausal Women: A Prospective Double-Blind Placebo Random Controlled Trial

Figure

Figure 1.
Figure 1. Changes in serum 25(OH)D. *Significant change pre and post (P < 0.001). ŦSignificant greater increase compared to other groups (P = 0.019).

Tables

Table 1. Participants’ Descriptive Data
 
GroupAge (years)Height (cm)Weight (kg)BMI
ContraceptionSupplementation
YesVit D (n = 10)24 ± 5.99165.56 ± 9.7467.0 ± 9.2320.18 ± 1.92
Placebo (n = 9)30 ± 11.62161.50 ± 9.0364.3 ± 5.6319.88 ± 1.39
NoVit D (n = 10)22 ± 4.55169.22 ± 6.4170.6 ± 12.3320.77 ± 2.97
Placebo (n = 9)27 ± 10.71166.33 ± 6.3268.8 ± 9.2820.66 ± 2.61

 

Table 2. Descriptive Pre and Post Serum 25(OH)D Data
 
GroupSerum 25(OH)D
ContraceptionSupplementationPre (nmol/L)Post (nmol/L)
*Significant change pre and post (P < 0.001). ŦSignificant greater increase compared to other groups (P = 0.019).
YesVit D (n = 10)52.3 ± 33.6598.3 ± 37.02*Ŧ
Placebo (n = 9)43.5 ± 19.0045.9 ± 2.06
NoVit D (n = 10)47.5 ± 24.8569.6 ± 24.21*
Placebo (n = 9)39.0 ± 14.8644.2 ± 15.79